EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H13N3O2S |
| Net Charge | 0 |
| Average Mass | 299.355 |
| Monoisotopic Mass | 299.07285 |
| SMILES | COc1ccc2sc(-c3cncc(/N=C(\C)O)c3)nc2c1 |
| InChI | InChI=1S/C15H13N3O2S/c1-9(19)17-11-5-10(7-16-8-11)15-18-13-6-12(20-2)3-4-14(13)21-15/h3-8H,1-2H3,(H,17,19) |
| InChIKey | JLUXIHDOQQZMIZ-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | EC 2.7.11.* (protein-serine/threonine kinase) inhibitor An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any protein-serine/threonine kinase (EC 2.7.11.*). EC 2.7.12.1 (dual-specificity kinase) inhibitor An EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor that inhibits the action of dual-specificity kinase (EC 2.7.12.1). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-[5-(5-methoxy-1,3-benzothiazol-2-yl)pyridin-3-yl]acetamide (CHEBI:233242) has role EC 2.7.11.* (protein-serine/threonine kinase) inhibitor (CHEBI:76812) |
| N-[5-(5-methoxy-1,3-benzothiazol-2-yl)pyridin-3-yl]acetamide (CHEBI:233242) has role EC 2.7.12.1 (dual-specificity kinase) inhibitor (CHEBI:195525) |
| N-[5-(5-methoxy-1,3-benzothiazol-2-yl)pyridin-3-yl]acetamide (CHEBI:233242) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| N-[5-(5-methoxy-1,3-benzothiazol-2-yl)pyridin-3-yl]acetamide |
| Synonym | Source |
|---|---|
| PST-001 | SUBMITTER |
| Citations |
|---|